2nd Edition of International Conference on Gastroenterology
September 24-26, 2026, London,UK
Immune-Mediated & Eosinophilic GI Disorders
Immune-mediated and eosinophilic gastrointestinal disorders are increasingly recognized as important causes of chronic GI symptoms across all age groups. These conditions arise from dysregulated immune responses involving eosinophils, mast cells, and cytokine-mediated inflammation, often without overt structural abnormalities. Patients may present with abdominal pain, dysphagia, diarrhea, weight loss, or malnutrition. Advances in endoscopic techniques, histopathology, and molecular profiling have improved diagnostic accuracy. Management strategies include dietary interventions, pharmacologic immunomodulation, and emerging biologic therapies targeting specific inflammatory pathways. This topic highlights evolving insights into disease mechanisms, diagnostic challenges, and novel treatment approaches aimed at reducing inflammation and improving patient quality of life.
Gilles R G Monif
University of Florida, United States
Tracy E Hill
Ph.D. & Associates LLC, United States
John Andrew Sutton
Gastria Ltd, United Kingdom
Venturi Sebastiano
AUSL-ROMAGNA, Italy
Yaffa Machnes
Bar-Ilan University, Israel
Jose Luis Braga de Aquino
Pontifical Catholic University of Campinas, Brazil
Youcun Qian
Shanghai Institute of Nutrition and Health, ChinaSubmit your abstract Today
Title : Gastroenterology viewed through a glass darkly: An IDI perspective
Gilles R G Monif, University of Florida, United States
Title : The psychology of disorders of gut-brain interactions
Tracy E Hill, Ph.D. & Associates LLC, United States
Title : How epigastric impedance would radically change gastric medicine
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Role of Pregnancy (P) and breastfeeding on Gallstones (GS) related Acute Pancreatitis (AP)
Alberto Maringhini, La Maddalena, Italy
Title : From the birth of atoms to life: Iodine and caesium, angels and demons of evolutionary biology, in pancreatic cancer and diabetes
Venturi Sebastiano, AUSL-ROMAGNA, Italy
Title : The IL17REL gene encodes a decoy receptor of IL-17 family cytokines to control gut inflammation
Youcun Qian, Shanghai Institute of Nutrition and Health, China